Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Transversus Abdominis Plane Block After Robot-assisted Laparocopic Hysterectomy (TAP-block)

This study has been terminated.
(Due to local restructering, further recruting was not possible)
Information provided by (Responsible Party):
Copenhagen University Hospital at Herlev Identifier:
First received: December 30, 2011
Last updated: August 21, 2013
Last verified: August 2013
The purpose of this study is to investigate the effectiveness of Transversus Abdominis Plane (TAP) block as a part of a multimodal postoperative pain management after robot-assisted laparoscopic hysterecomy.

Condition Intervention Phase
Procedure: TAP block
Procedure: Placebo TAP block
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effekt of Transversus Abdominis Plane (TAP) Block After Robot-assisted Laparocopic Hysterectomy

Resource links provided by NLM:

Further study details as provided by Copenhagen University Hospital at Herlev:

Primary Outcome Measures:
  • Total opioid consumption [ Time Frame: 0-24 hours ]
    Opioid consumption via PCA-pump

Secondary Outcome Measures:
  • Pain during rest and cough [ Time Frame: 1,2,4,8,18 and 24 hours ]
    VAS-pain score at rest and at cough

  • Postoperative nausea and vomiting [ Time Frame: 1,2,4,8,18 and 24 hours ]
    Nausea score 0-3 No. of vomits

Enrollment: 70
Study Start Date: December 2011
Study Completion Date: July 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: TAP block
TAP block with ropivacaine
Procedure: TAP block
Bilateral UL-guided TAP block with 20 ml of ropivacaine 0.5 %
Other Name: Naropin 0.5%
Placebo Comparator: Placebo TAP block
Sham block with saline
Procedure: Placebo TAP block
Bilateral placement of 20 ml of saline 0.9 % in the transversus abdominis plane
Other Name: Saline 0.9%


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18-80
  • BMI 17-40
  • Written consent
  • Can cooperate

Exclusion Criteria:

  • Drug and alcohol abuse
  • Consumption of opioids
  • Drug allergy
  • Infection at insertion point of needle
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01504386

Herlev Univerity Hospital, Department of Anaesthesia
Herlev, Denmark, 2730
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Principal Investigator: Henrik Torup, MD Herlev University Hospital, Copenhagen
  More Information

Responsible Party: Copenhagen University Hospital at Herlev Identifier: NCT01504386     History of Changes
Other Study ID Numbers: SM1-HT-2011
Study First Received: December 30, 2011
Last Updated: August 21, 2013 processed this record on May 25, 2017